Test may ‘revolutionise’ treatment of cancer

A GENETIC “fingerprint” test has been developed that matches cancer patients to the right chemotherapy drugs.

The breakthrough could mean an end to “trial and error” cancer treatment. Instead, doctors will know immediately which drugs most aggressively and effectively attack an individual patient’s cancer.

One scientist involved in the research said the test could potentially “revolutionise cancer care”.